Zuckerman Spaeder LLP Wins First Case Testing Generic Exclusivity Forfeiture Rules

Zuckerman Spaeder LLP client Roxane Laboratories, Inc. secured an important victory in the first case testing the generic exclusivity forfeiture provision of the Federal Food, Drug and Cosmetic Act (FDCA). Please click below for the press release.